Tradestie Institutional Equity Comparison Engine
EEIQ vs UPC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
UPC Overall Edge
UPC Captures Institutional Edge (1โ1 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Universe Pharmaceuticals Inc. Ordinary Shares (UPC) driven by superior Growth & Margin while EEIQ counters with relative strength in Momentum & Technical. Fundamentally, EEIQ trades at N/M Forward P/E with -47.4% operating margin (+16.8% YoY revenue) versus UPC at N/M Forward P/E and -11.8% operating margin (-1.3% YoY). In options structure, EEIQ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against UPC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
EEIQ N/M vs UPC N/M Fwd P/E
Growth & Margin Winner
UPC
Op Margin -47.4% vs -11.8% ยท YoY +16.8% vs -1.3%
Momentum & Technical Winner
EEIQ
1Y +846.1% vs -69.8% ยท 52W Pos 24% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
EEIQ
NASDAQ
EpicQuest Education Group International Limited Common Stock
Services-Educational Services
$3.11
-5.18% 1D
Market Cap
$5.4M
1M Return
-33.97%
1Y Return
+846.15%
Forward P/E
N/M
Unified AI Score
39.2 / 100
SELL
Tech 35.0
Fund 42.0
Flow 50.0
Mom 55.0
UPC
NASDAQ
Universe Pharmaceuticals Inc. Ordinary Shares
Pharmaceutical Preparations
$1.08
-20.59% 1D
Market Cap
$6.8M
1M Return
-75.34%
1Y Return
-69.75%
Forward P/E
N/M
Unified AI Score
41.4 / 100
SELL
Tech 25.0
Fund 53.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EEIQ +846.15%
UPC -69.75%
Spread: +989.42 pp (EEIQ Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
EEIQ TTM Op. Margin: -47.4%
UPC TTM Op. Margin: -11.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EEIQ vs UPC. Trailing 12-month operating profitability (EEIQ -47.4% vs UPC -11.8%) and valuation multiples (EEIQ N/M vs UPC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EEIQ | UPC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.4M | $6.8M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +16.8% | -1.3% | Higher Growth | EEIQ |
| Operating Margin (TTM) Profitability | -47.4% | -11.8% | Higher Margin | UPC |
| Net Profit Margin Profitability | -51.1% | -10.9% | Higher Margin | UPC |
| Return on Equity (ROE) Capital Efficiency | -46.8% | -3.5% | Higher ROE | UPC |
| 52-Week Range Position Momentum | 24% ($0โ$13) | 0% ($1โ$18) | Stronger Trend | EEIQ |
| Beta / 30D Volatility Risk Regime | -1.80ฮฒ ยท 48% Vol | 4.56ฮฒ ยท 163% Vol | Lower Realized Risk | EEIQ |
| Unified Institutional Score Composite Signal | 39.2 / 100 (SELL) | 41.4 / 100 (SELL) | Higher Composite | UPC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EEIQ vs UPC Buy Guide
EEIQ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
UPC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EEIQ nor UPC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.